The University of Chicago Header Logo

Connection

Rochelle Naylor to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Rochelle Naylor has written about Diabetes Mellitus, Type 2.
Rochelle Naylor
Connection Strength
3.417
Diabetes Mellitus, Type 2
  1. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
    View in: PubMed
    Score: 0.325
  2. Pediatric Monogenic Diabetes: A Unique Challenge and Opportunity. Pediatr Ann. 2019 Aug 01; 48(8):e319-e325.
    View in: PubMed
    Score: 0.321
  3. GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants. Diabetes Res Clin Pract. 2019 May; 151:231-236.
    View in: PubMed
    Score: 0.316
  4. Economics of Genetic Testing for Diabetes. Curr Diab Rep. 2019 03 27; 19(5):23.
    View in: PubMed
    Score: 0.314
  5. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry. Acta Diabetol. 2019 Apr; 56(4):405-411.
    View in: PubMed
    Score: 0.307
  6. Clinical Management of Women with Monogenic Diabetes During Pregnancy. Curr Diab Rep. 2018 02 15; 18(3):12.
    View in: PubMed
    Score: 0.290
  7. Adolescent non-adherence reveals a genetic cause for diabetes. Diabet Med. 2015 Jun; 32(6):e20-3.
    View in: PubMed
    Score: 0.241
  8. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
    View in: PubMed
    Score: 0.214
  9. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol (Oxf). 2011 Oct; 75(4):422-6.
    View in: PubMed
    Score: 0.187
  10. Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):1175-1186.
    View in: PubMed
    Score: 0.127
  11. Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young. Diabetes. 2026 01 01; 75(1):215-222.
    View in: PubMed
    Score: 0.125
  12. GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).
    View in: PubMed
    Score: 0.119
  13. High Prevalence of A-ß+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
    View in: PubMed
    Score: 0.110
  14. Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY). Diabetes Care. 2023 03 01; 46(3):608-612.
    View in: PubMed
    Score: 0.103
  15. Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry. Genet Med. 2023 04; 25(4):100019.
    View in: PubMed
    Score: 0.102
  16. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2). Diabetes. 2019 08; 68(8):1565-1576.
    View in: PubMed
    Score: 0.079
  17. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
    View in: PubMed
    Score: 0.072
  18. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated. Acta Diabetol. 2016 Oct; 53(5):703-8.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.